INTELLIA THERAPEUTICS, INC. Accumulated Other Comprehensive Income
INTELLIA THERAPEUTICS, INC. (NTLA) had Accumulated Other Comprehensive Income of -$1.03 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.03M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$240.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.03M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $990.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$1.03M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$240.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.03M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $990.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $653.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.06M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $605.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$1.16M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$947.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$2.26M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$3.57M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$3.87M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$2.68M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$7.46M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$9.37M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$9.55M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$8.06M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$2.63M 10-K · filed 2023-02-23 |
| 2021-09-30 | -$174.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$13.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$12.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $31.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $155.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $373.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $261.00K 10-K · filed 2021-02-26 |
| 2019-09-30 | $336.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $255.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $59.00K 10-Q · filed 2019-05-02 |
| 2018-12-31 | -$28.00K 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |